These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 25944644)
21. Patient characteristics of suspected mast-cell activation syndrome with sinonasal obstruction: a single institution experience. Kim JH; Xi S; Ference EH; Ge M; Liu MM; Wrobel BB Int Forum Allergy Rhinol; 2020 Aug; 10(8):996-1000. PubMed ID: 32407593 [TBL] [Abstract][Full Text] [Related]
23. Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management. Hamilton MJ Curr Gastroenterol Rep; 2024 Apr; 26(4):107-114. PubMed ID: 38353900 [TBL] [Abstract][Full Text] [Related]
24. The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome. Butterfield J; Weiler CR J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2533-2541. PubMed ID: 32142966 [TBL] [Abstract][Full Text] [Related]
25. [Tryptase: A practical guide for the physician]. Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S Rev Med Interne; 2020 Nov; 41(11):748-755. PubMed ID: 32712042 [TBL] [Abstract][Full Text] [Related]
26. Using the Right Criteria for MCAS. Gulen T Curr Allergy Asthma Rep; 2024 Feb; 24(2):39-51. PubMed ID: 38243020 [TBL] [Abstract][Full Text] [Related]
33. H1-antihistamines for primary mast cell activation syndromes: a systematic review. Nurmatov UB; Rhatigan E; Simons FE; Sheikh A Allergy; 2015 Sep; 70(9):1052-61. PubMed ID: 26095756 [TBL] [Abstract][Full Text] [Related]
34. Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction. Valent P; Akin C J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1109-1114. PubMed ID: 30961836 [TBL] [Abstract][Full Text] [Related]
35. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels. Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272 [TBL] [Abstract][Full Text] [Related]
36. Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine. Valent P; Akin C; Nedoszytko B; Bonadonna P; Hartmann K; Niedoszytko M; Brockow K; Siebenhaar F; Triggiani M; Arock M; Romantowski J; Górska A; Schwartz LB; Metcalfe DD Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261124 [TBL] [Abstract][Full Text] [Related]
37. Human mast cell tryptase in biology and medicine. Vitte J Mol Immunol; 2015 Jan; 63(1):18-24. PubMed ID: 24793463 [TBL] [Abstract][Full Text] [Related]
39. On the role of PGD2 metabolites as markers of mast cell activation in asthma. O'Sullivan S Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758 [TBL] [Abstract][Full Text] [Related]
40. Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome. Giannetti MP; Akin C; Castells M J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1196-1201. PubMed ID: 32276688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]